Full Text (PDF)
Original Article

Evaluation of Market Samples of ‘Naga Bhasma’ Using ‘Namburi Phased Spot Test’ (NPST)

Vijaykumar. S. Kotrannavar* , Vijaykumar. S. Kotrannavar* , Savita S. Angadi**

Author Information

Licence:




Indian Journal of Ancient Medicine and Yoga 9(3):p 95-98, July - September 2016. | DOI: DOI: https://dx.doi.org/10.21088/ijamy.0974.6986.9316.3

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

  Naga Bhasma (calx of Naga i.e. Lead), an unique mineral product used traditionally in the management of Prameha (Diabetes) and Netra Vikaras (Eye disorders) was prepared according to the prescription in the Ayurvedic classics and subjected to various bhasma pariksha (tests for calx), including the Namburi Phased Spot Test (NPST), one of the qualitative tests described for various Ayurvedic preparations. NPST helps to differentiate between, and thus identify, various hasmas (calx). It depends upon the pattern of the spot, which develops after a specific chemical reaction. Naga bhasma prepared by classical reference in our department along with three market samples were subjected to above said tests and the results were compared. The various bhasmas exhibited marked differences in color, and though NPST yielded desired results for all the samples, there were difference in their spot pattern and color. The bhasma prepared in our department had produced the nearest results to standard NPST of Naga Bhasma

Keywords: amburi Phased Spot Test (NPST); Naga Bhasma.


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: DOI: https://dx.doi.org/10.21088/ijamy.0974.6986.9316.3

Keywords


Article Level Metrics

Last Updated

Sunday 21 June 2026, 19:51:04 (IST)


1746

Accesses

3
492
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share